BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6102877)

  • 21. The use of the AIMS questionnaire in the evaluation of sulphasalazine treatment in rheumatoid arthritis.
    Pelísková Z; Trnavský K; Vácha J
    Z Rheumatol; 1987; 46(3):124-8. PubMed ID: 2442919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study.
    Gough A; Sheeran T; Arthur V; Panayi G; Emery P
    Scand J Rheumatol; 1994; 23(1):46-8. PubMed ID: 7906428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.
    Chalmers IM; Sitar DS; Hunter T
    J Rheumatol; 1990 Jun; 17(6):764-70. PubMed ID: 1974926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylsulphasalazine in rheumatoid arthritis.
    Astbury C; Hill J; Lowe JR; Campbell D; Bird HA
    Br J Rheumatol; 1990 Dec; 29(6):465-7. PubMed ID: 1979513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toleration, side-effects and efficacy of sulphasalazine in rheumatoid arthritis patients of different ages.
    Wilkieson CA; Madhok R; Hunter JA; Capell HA
    Q J Med; 1993 Aug; 86(8):501-5. PubMed ID: 8105504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy.
    Farr M; Tunn EJ; Symmons DP; Scott DG; Bacon PA
    Br J Rheumatol; 1989 Apr; 28(2):134-8. PubMed ID: 2565128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.
    Bax DE; Greaves MS; Amos RS
    Br J Rheumatol; 1986 Aug; 25(3):282-4. PubMed ID: 2873862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.
    Farr M; Symmons DP; Bacon PA
    Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sulfasalazine in the treatment of rheumatoid arthritis. A multicenter open study of 150 patients during 6 months].
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):707-13. PubMed ID: 1363986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM; Carty JE
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
    Situnayake RD; McConkey B
    J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulphasalazine therapy in rheumatoid arthritis: qualitative changes in lymphocytes and correlation with clinical response.
    Samanta A; Webb C; Grindulis KA; Fleming J; Sheldon PJ
    Br J Rheumatol; 1992 Apr; 31(4):259-63. PubMed ID: 1348199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.
    Farr M; Tunn E; Crockson AP; Bacon PA
    Clin Rheumatol; 1984 Dec; 3(4):473-81. PubMed ID: 6151882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sulphasalazine on faecal flora in patients with rheumatoid arthritis: a comparison with penicillamine.
    Neumann VC; Shinebaum R; Cooke EM; Wright V
    Br J Rheumatol; 1987 Oct; 26(5):334-7. PubMed ID: 2889501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additive triple DMARD combination therapy of a low dose of sulfhydryl compounds, sulfasalazine and methotrexate in the treatment of rheumatoid arthritis: a clinical trial.
    Nishiya K; Hisakawa N; Tahara K; Matsumori A; Ito H; Hashimoto K; Nakatani K; Takatori K
    Acta Med Okayama; 1999 Dec; 53(6):275-9. PubMed ID: 10631383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1987 May; 46(5):398-402. PubMed ID: 2884932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulphasalazine in rheumatoid arthritis.
    Boey ML; Lee E; Feng PH
    Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
    [No Abstract]   [Full Text] [Related]  

  • 40. Do drugs change the course of rheumatoid arthritis?
    Wright V; Amos R
    Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.